Kara Nordin is an accomplished inventor based in Des Plaines, IL (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of viral infections. Her work has led to the development of innovative methods that enhance the accuracy and efficiency of hepatitis C virus detection.

Latest Patents

Kara Nordin holds 1 patent for her invention titled "Assay for detecting hepatitis C virus (HCV)." This patent encompasses methods, kits, and compositions designed for amplifying and detecting the human hepatitis C virus in various samples. The invention utilizes a combination of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes to achieve reliable results.

Career Highlights

Kara Nordin is currently employed at Abbott Molecular Inc., a leading company in molecular diagnostics. Her role at Abbott has allowed her to work on cutting-edge technologies that address critical health challenges. Her expertise in the field has positioned her as a valuable asset to her team and the broader scientific community.

Collaborations

Kara has collaborated with notable colleagues, including Dan Toolsie and Shihai X Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kara Nordin's contributions to the field of medical diagnostics, particularly through her patent for hepatitis C virus detection, highlight her role as a leading inventor. Her work continues to impact the healthcare industry positively, showcasing the importance of innovation in addressing public health challenges.

Profile summary based on public USPTO records.